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A B S T R A C T
For more than ﬁve years, high-dimensional mass cytometry has been employed to study immunology. However,
these studies have typically been performed in one laboratory on one or few instruments.
We present the results of a six-center study using healthy control human peripheral blood mononuclear cells
(PBMCs) and commercially available reagents to test the intra-site and inter-site variation of mass cytometers
and operators. We used prestained controls generated by the primary center as a reference to compare against
samples stained at each individual center. Data were analyzed at the primary center, including investigating the
eﬀects of two normalization methods.
All six sites performed similarly, with CVs for both Frequency of Parent and median signal intensity (MSI)
values < 30%. Increased background was seen when using the premixed antibody cocktail aliquots at each site,
suggesting that cocktails are best made fresh. Both normalization methods tested performed adequately for
normalizing MSI values between centers. Clustering algorithms revealed slight diﬀerences between the pre-
stained and the sites-stained samples, due mostly to the increased background of a few antibodies. Therefore, we
believe that multicenter mass cytometry assays are feasible.
1. Introduction
For a few decades, ﬂuorescent ﬂow cytometry has been the standard
method for phenotypic analysis of mixed populations of cells. However,
spectral overlap between ﬂuorophores limits the number of simulta-
neous probes per experiment. Mass cytometry is an alternate method
which uses elemental tags instead of ﬂuorophores for labeling probes,
allowing analysis by inductively-coupled plasma mass spectrometry.
This typically avoids the issue of overlap between detection channels,
and allows the routine use of> 40 simultaneous probes.
While challenging to coordinate, multicenter studies have been
successfully performed in ﬂuorescence ﬂow cytometry (Finak et al.,
2016; Kalina et al., 2015; Maecker et al., 2005). Although the number
of research publications involving mass cytometry have continued to
increase since the ﬁrst publication of comprehensive immunological
data generated by CyTOF by Bendall et al. in 2011 (Bendall et al.,
2011), most studies have been performed in a single lab at a single site
(Brodin et al., 2015) Few studies have tested machine-to-machine
variation, and in recent years, the use of normalization beads to account
for intra-instrument day-to-day variation has become common practice
(Tricot et al., 2015; Finck et al., 2013). While one multicenter study was
reported at a conference (Nasaar et al., 2015) and another multicohort
analysis was recently published (Blazkova et al., 2017), no systematic
multicenter CyTOF assessment has been published to compare issues of
staining and instrument performance consistency. Here, we designed a
staining panel from commercially-available reagents to allow mea-
surement of major cell populations in cryopreserved PBMCs. We
adapted a method (Sumatoh et al., 2017) to cryopreserve prestained
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cells to use as an external control for each of six centers across three
countries. Reagents, unstained cells, calibration beads, and prestained
cells were shipped to each center. Each center then performed the
staining protocol on the unstained cells and then ran the newly-stained
samples and the pre-stained samples on CyTOF2 instruments after daily
tuning. The resulting ﬁles were sent back to the main center for stan-
dardized analysis by a single researcher.
2. Materials and methods
2.1. Materials and reagents
The human Peripheral Blood panel kit (#201304), containing 17
antibodies, MAXPAR Cell Staining Buﬀer (CSB), and MAXPAR Fix/
Perm Buﬀer was purchased from Fluidigm Corporation (South San
Francisco, CA). Additionally, CD56-Yb176 (#3176008B), CD7-Eu153
(#3153014B), CD33-Gd158 (#3158001B), Cisplatin (natural-abun-
dance, 5 mM stock; #201064), Ir-intercalator stock solution
(#201192B), and EQ four-element beads (#201078) were also pur-
chased from Fluidigm. RPMI (HyClone #SH30027.01), FBS (heat-in-
activated before use) (Atlanta Biologicals, #S11150), Pen-Strep-Gluta-
mine (100×) (HyClone #SV30082.01), and Benzonase (25 × 105 U/
mL; Pierce Antibodies #88701), were purchased from Fisher Scientiﬁc.
PBS (10× stock; Rockland #MB-008), 0.1 μm spin ﬁlters (Millipore
#UFC30VV00), and 5 mL blue-cap cell strainer ﬁlter tubes (Falcon
#352235) were purchased from Fisher Scientiﬁc. DMSO was purchased
from Sigma (#D8418). MilliQ water was used to make 1× PBS
(CyPBS). Note: it is important that all MilliQ water and buﬀers are
stored in bottles that have not been washed with soap, due to the
barium content of many commercial soaps.
Peripheral blood mononuclear cells (PBMCs) were isolated by
Ficoll-paque density gradient centrifugation from a healthy donor leu-
kocyte reduction system chamber obtained from the Stanford Blood
Center. After isolation, the cells were dispensed into aliquots of 10
million cells per vial and cryopreserved in the vapor phase of liquid
nitrogen until use.
2.2. Shipping of samples
The Human Immune Monitoring Center (HIMC) was the primary
center and prepared all reagents for all six centers. For consistency, all
reagents were purchased by the HIMC and then distributed to all sites.
For each site, two packages were prepared. The concentrated antibody
cocktail (see below), CSB, Fix/Perm Buﬀer, and EQ beads were shipped
at 4 °C with gel cold packs. The aliquots of prestained samples (see
below), unstained cells, Ir intercalator, and cisplatin were shipped on
dry ice.
2.3. Preparation of antibody cocktail
The 20 undiluted antibodies were mixed at appropriate titer to
create 368 μL of concentrated cocktail (Table S1), suﬃcient for both the
prestained cell samples and for the site-stained samples. The cocktail
was then split into aliquots of 6 × 35 μL for each site and stored at 4 °C,
with the rest used on the day of mixing to create the prestained control
cells.
2.4. Multicenter cell staining procedure
The staining protocol was modiﬁed from the manufacturer's
“MaxPar Cell Surface Staining Protocol”. Cryopreserved PBMCs were
thawed at 37 °C in a water bath, washed by resuspension in 10 mL of
warm RPMI containing 10% heat-inactivated FBS, 1× Pen-Strep-
Glutamine, and Benzonase (25 U/mL ﬁnal concentration). The cells
were collected by centrifugation (RCF = 480, 10 min, room tempera-
ture), the supernatant removed, and the cells resuspended in fresh
RPMI and centrifuged again. The cells were diluted to 1 mL in CSB, then
measured for viability and cell count by Vicell (Beckman Coulter). Two
aliquots (sample A and sample B) of 2 million viable cells each were
dispensed into 5 mL polystyrene tubes (Falcon). 2 mL of CSB was added
to each tube, centrifuged (10 min, RCF = 480, R.T.), and supernatant
discarded by aspiration.
For antibody staining, the cells were resuspended in a volume of
50 μL CSB. Sixty-ﬁve microliters of CSB was then added to the 35 μL of
concentrated antibody cocktail (100 μL total). The cocktail was placed
in a 0.1 μm spin ﬁlter and centrifuged in a microcentrifuge (10 min,
RCF = 14,000, R.T.) to elute. If necessary, the volume was adjusted to
100 μL with CSB. Fifty microliters of diluted antibody cocktail were
then added to each cell sample, mixed by pipetting, and incubated at
room temperature for 30 min. The samples were washed twice with
2 mL 1× CyPBS (diluted to 1× with MilliQ water), centrifuged
(10 min, RCF = 480, R.T.) and supernatant removed by aspiration.
For cisplatin live-dead staining, 1.5 mL of 1× CyPBS was added to a
tube containing 2 μL of 5 mM cisplatin. A two-fold dilution was made
by adding 750 μL of the cisplatin to 750 μL of 1× CyPBS. The cells
were resuspended in the residual volume of CyPBS, then 100 μL of di-
luted cisplatin were added to each sample and incubated for 5 min at
room temperature (Note: do not exceed 5 min!).
Following the cisplatin incubation, the samples were washed twice
with 2 mL CSB by centrifugation (10 min, RCF = 480, R.T.) and as-
piration. The cells were resuspended in the residual volume by gently
pipetting after the ﬁnal wash/aspiration. Next, 2 μL of Ir intercalator
stock were diluted with 2 mL of Fix/Perm Buﬀer and 1 mL added to
each tube before overnight incubation at 4 °C.
The following day, the cells were each washed twice with 2 mL of
CSB by centrifugation (10 min, RCF = 800, 4 °C) and aspiration. Each
replicate tube (A and B) of cells was resuspended in 2 mL of CSB, then
split into two tubes of 1 million cells (sample A1 and A2, sample B1 and
B2). Samples A2 and B2 were then placed at 4 °C overnight.
The prestained control cells were processed as 7 aliquots of 2 mil-
lion cells each, using the same protocol. During the ﬁnal CSB re-
suspension, the aliquots were pooled, then re-split into 13 aliquots of
approximately 1 million cells. Twelve aliquots were centrifuged
(10 min, RCF = 800, 4 °C) and the supernatant removed by aspiration.
Each cell pellet was resuspended in 100 μL of freezing media (10%
DMSO in 90% heat-inactivated FBS) and frozen at −80 °C until use
(Sumatoh et al., 2017). The thirteenth aliquot was not placed in
freezing media; instead, it was washed with MilliQ water and run on the
CyTOF2 as a never-frozen reference (see below).
2.5. Sample acquisition on CyTOF2
Of the six sites, Centers 1, 4, 5, and 6 had CyTOF2 instruments
(Fluidigm). Centers 2 and 3 had CyTOF1 (Fluidigm) instruments that
had been upgraded by the manufacturer to CyTOF2 hardware speciﬁ-
cations and software, resulting in machines comparable to CyTOF2
instruments (often called CyTOF1.5).
Prestained sample 1 was thawed on ice and transferred to a 5 mL
polystyrene tube. Sample A1, A2, and prestained sample 1 were washed
twice with 2 mL MilliQ water by centrifugation (10 min, RCF = 800,
4 °C), and aspiration. EQ calibration beads were diluted 10-fold in
MilliQ water. The CyTOF2 was started and left to warm up for 20 min,
then tuned with Tuning Solution (Fluidigm) according to the manu-
facturer's recommendation. From the QC log from the Results tab after
tuning, the values for Resolution; Dual Slope values for Cs and Tm;
Mean Dual Count Tb value; RSD (Dual) values for Tb, Cs, La, Tm, Ir;
Mean 155Gd Dual counts; Analog Controls: Detector Voltage, Nebulizer
Gas, Makeup Gas, and Current were recorded (Table S2).
Immediately before injection, each cell pellet was diluted to 1 mL
(~0.8 × 106 cells/mL) with the 0.1× EQ beads and ﬁltered into 5 mL
blue cell strainer cap tubes. Each sample was acquired in 2 × 500 μL
injections (using both sample loops) as a single FCS3.0 ﬁle. At this
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point, the raw FCS ﬁles were not normalized and EQ beads were not
removed. The next day, sample A2, sample B2, and prestained sample 2
were processed and recorded in the same way.
2.6. Data analysis
The raw FCS ﬁles and QC log reports were sent back to Stanford
University for standardized analysis. M. Leipold performed all manual
gating analysis (Mac FlowJo X version 10.0.7r2; Supp. Fig. S6). In ad-
dition to the raw ﬁles, the FCS ﬁles were normalized in two ways: the
Fluidigm normalizer built into the CyTOF2 v.6.0.626 software using the
Passport P13H2302 (“Fluidigm v1”) and Passport P13H2302_ver2
(“Fluidigm v2”) (User Guide UG13-02_150501); and the MATLAB
normalizer from Finck et al. (v.7.14.0.739 run in MATLAB R2012a;
Finck et al., 2013). These batch-normalized ﬁles were then re-analyzed
in FlowJo. All 151 FCS ﬁles are available at Flow Repository under
accession FR-FCM-ZY3Z. Frequency of Parent and Median intensity
data for all ﬁles were then exported for analysis in JMP (SAS) by G.
Obermoser.
The two current normalization programs diﬀer in their metho-
dology: the Fluidigm algorithm included in the CyTOF software nor-
malizes ﬁles according to a set of external reference values determined
by Fluidigm (User Guide UG13-02_150501). This allows each ﬁle to be
processed separately if desired, but does not allow for variation in peak
mass sensitivity between diﬀerent machines as observed in Tricot et al.
(Tricot et al., 2015). Additionally, there is minimum required number
of EQ beads per ﬁle in order for the normalizer to function properly
(typically at least 50 beads per 100 s of data).
In contrast, the MATLAB algorithm uses the EQ beads within each
ﬁle to create a local set of values per ﬁle (Finck et al., 2013). Next, all
the ﬁles included in that batch are compared to generate a global ca-
libration value, which is then used to normalize all the ﬁles together for
each channel. This method allows for variation in peak mass sensitiv-
ities during the local value generation, but typically requires that all
ﬁles to be compared are processed in the same batch (although a recent
software update allows the designation of a reference ﬁle to which all
others are normalized). This method does not have bead-count re-
quirements to function, but normalization will be more representative
of the ﬁle if an adequate number of beads are present.
2.7. Clustering analysis
Normalization is critical before any clustering analysis. Here, the
MATLAB-all normalized ﬁles were chosen in order to have all 6 nor-
malized ﬁles from each of the 6 sites (Table 1). In order for any ad-
vanced data analysis methods to be performed, the ﬁles must have the
same parameter names. Therefore, due to parameter naming diﬀerences
between some sites (see Discussion below), the ﬁle parameters were
harmonized using the cytofCore package (https://github.com/
nolanlab/cytofCore), using Center 2′s P1 sample as the reference tem-
plate. After this, the ﬁles were gated in FlowJo X to Live Intact Singlet
CD66− CD45+ CD235ab− CD61− events and re-exported as new
FCS ﬁles. These new ﬁles were used for SPADE3 and for Cytofkit ana-
lysis (below), and have been uploaded to the FlowRepository record as
a combined ZIPPED ﬁle.
The clustering algorithms chosen were PCA, SPADE3 (pre-compiled
Mac MATLAB stand-alone version; Qiu, 2017; http://pengqiu.gatech.
edu/software/SPADE/) and Cytofkit (Chen et al., 2016; https://github.
com/JinmiaoChenLab/cytofkit), which is an R software package con-
taining components for PCA and tSNE outputs for ClusterX (Chen et al.,
2016), Phenograph (Levine et al., 2015), and FlowSOM (Van Gassen
et al., 2015) algorithms. To explore the eﬀects of prestained vs site-
stained samples, the ﬁles were run as three sets with each algorithm:
the 12 P ﬁles only, the 24 AB ﬁles only, and all 36 ABP ﬁles. The set-up
parameters for each algorithm can be seen as screenshots in Suppl. Fig.
S8. In all cases, the 14 markers used for clustering were CD27-Er167,
CD3-Er170, CD123-Eu151, CD33-Gd158, CD14-Gd160, CD19-Nd142,
CD4-Nd145, CD8a-Nd146, CD16-Nd148, CD20-Sm147, CD11c-Tb159,
CD45RA-Tm169, HLA-DR-Yb174, and CD56-Yb176. All output results
for SPADE3 and for Cytofkit have been uploaded to the FlowRepository
record as ZIPPED ﬁles.
3. Results
3.1. Creating and storing prestained samples
Prestained cell samples are commonly used for longitudinal stan-
dardization. However, until recently, there was no information on long-
term storage of prestained samples for mass cytometry. In Nov 2014, a
Cytoforum (http://cytoforum.stanford.edu) post mentioned rescuing an
experiment by freezing in 10% DMSO/90% heat-inactivated FBS at
−80 °C when a CyTOF machine unexpectedly required repairs. This
protocol was recently published in detail (Sumatoh et al., 2017).
Therefore, after completing the entire staining procedure and including
the post-Ir washes, we tested 10% DMSO/90% heat-inactivated FBS.
We tested two timepoints: one week and one month of−80 °C storage.
These samples were compared with the results from another aliquot of
the same cell staining experiment that had remained in CSB, had never
been frozen, and had been run on the CyTOF2 as soon as staining was
complete (never stored). At one week, the 10% FBS samples were un-
changed relative to the never-frozen control (Fig. S1). There was no
further change in frequencies in the one month sample. Repeating the
freezing experiment gave similar results (not shown); therefore, 10%
DMSO/90% heat-inactivated FBS was chosen as the storage media for
the Prestained samples.
3.2. Comparisons to be made
There were two main purposes of the Multicenter Study (Fig. 1):
ﬁrst, to measure the reproducibility of each site performing their own
cell staining. This was measured by comparing the A and B samples vs
the Prestained samples. Second, running the same samples on two
successive days tested the day-to-day variability of each instrument. To
Table 1
Summary statistics for each center, for number of ﬁles before and after normalization.
Raw Fluidigm v1 Fluidigm v2 MATLAB-pass
Fluidigm
MATLAB-all
Number of ﬁles
Center 1 6 4 4 4 6
Center 2 6 4 5 4 6
Center 3 6 0 0 0 6
Center 4 6 6 6 6 6
Center 5 6 6 6 6 6
Center 6 6 6 6 6 6
Total 36 26 27 26 36
Average CV - Frequency of Parent - all ﬁles all populations
Center 1 11.5 11.0 11.1 11.6 14.3
Center 2 9.1 10.2 11.3 12.4 9.8
Center 3 12.8 – – – 16.2
Center 4 11.5 11.7 9.7 10.8 11.6
Center 5 13.9 14.1 15.1 14.9 30.0
Center 6 13.2 15.5 14.8 16.2 13.9
Average of all
centers
12.0 12.5 12.4 13.2 15.9
Average CV - MSI - all ﬁles all populations
Center 1 36.0 31.6 34.4 31.6 35.4
Center 2 16.6 19.7 25.6 21.5 17.2
Center 3 25.3 – – – 27.9
Center 4 32.5 31.1 34.8 30.1 30.4
Center 5 29.4 30.1 31.5 29.5 35.0
Center 6 29.9 39.8 30.0 27.8 26.7
Average of all
centers
28.3 30.5 31.3 28.1 28.8
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minimize variation due to antibody conjugation eﬃciency, only pre-
conjugated antibodies commercially available from Fluidigm were
used. To minimize variation in making the cocktail mixture, a master
stock of concentrated antibody was mixed and undiluted aliquots were
made for each site (Fig. 1). This same stock was also used fresh on the
same day to make the Prestained samples. To minimize variation in cell
frequency due to biological variation between donors, cryopreserved
PBMC from a single donor was used to make the Prestained samples and
additional PBMC aliquots were shipped to each site.
3.3. Eﬀect of antibody cocktail storage on staining
Relative to the Prestained samples, site-stained samples from all six
centers had much higher background for the negative population in
several channels (Supp. Fig. S2). This does not appear to be a shipping
artifact, as the two on-site Stanford centers were aﬀected as strongly as
the other four sites. It should be noted that not every antibody was
aﬀected: for example, the backgrounds for CD14 and CD16 were high,
while those for CD3 and CD56 were unchanged. This was presumably
due to antibody aggregation during storage as a concentrated cocktail,
since separate aliquots of exactly the same cocktail preparation had
been used fresh to process the Prestained samples. Due to delays in
shipping and/or sample processing at each center, there was a
minimum of two weeks between creation of the concentrated cocktail
and the ﬁrst site use for staining. Even with increased background, it
was still always possible to resolve the populations of interest. The
signal intensities of the positive populations were unchanged.
3.4. Normalization
The inclusion of the EQ calibration beads allowed us to batch-nor-
malize all the raw ﬁles. The EQ beads contain four elements (Ce, Eu,
Ho, and Lu) with a total of seven isotopes distributed across the CyTOF
mass window. Therefore, using the beads as a constant reference
throughout each sample allows normalization of the ﬁles by inter-
polation.
3.5. Intra- and inter-site diﬀerences-manual gating
Variation in sensitivity between sites was observed even in the EQ
calibration bead channels (Fig. 2). Each site was consistent from Day 1
to Day 2, indicating that each site's instrument was stable, but diﬀerent
from the other sites in sensitivity. Normalizing using either method
made the six sites noticeably more similar in Median signal intensities.
For all samples of all centers pooled together, there was little dif-
ference in Frequency of Parent between the raw ﬁles pooled from all
sites and the same ﬁles normalized by either method (Fig. 3; Table 1;
average CV < 20%; individual gated population CV typically< 25%
in Table S3). This was expected, since all gates for each ﬁle were
manually adjusted during analysis. Additionally, the CV of Frequency of
Parent between sites was quite narrow, ranging only 12–16% (Table 1
average pooled CV < 16%). Even for low-frequency populations, the
CV for individual centers seldom went above 30% (Supp. Fig. S3).
For median signal intensities (MSI), populations with higher signal
(> 100 Dual Counts) had smaller CVs, typically< 25% (Fig. 4A, Supp.
Fig. S5). As the signal intensity decreased, the CVs increased, but
usually remained< 50% (Fig. 4B). Taking all gated populations to-
gether, the average CV for each center was around 30% (Table 1).
When pooling the data for all centers, the main eﬀect of either nor-
malization method was to increase the signal intensity across all po-
pulations, with little eﬀect on average pooled CV (CV ~ 30%, Fig. 4,
Table 1, Table S4). Center 2 and Center 3 often had the lowest MSI
values but still acceptable resolution (Supp. Fig. S4, Supp. Fig. S5),
while Center 4 and Center 5 typically had the highest MSI values.
As discussed above, the Fluidigm normalizer has a minimum bead
requirement. If this is not met due to insuﬃcient beads, the normal-
ization program can fail. Three sites were aﬀected by this (total of 9/36
ﬁles), including all six ﬁles from one site (Table 1). This was probably
due to inadequate resuspension of the EQ bead aliquot supplied as part
of the study reagents, leading to too few beads in the solution used to
resuspend the cells during sample running. In case this would aﬀect the
comparison of the Fluidigm and MATLAB normalizers, the MATLAB
normalizer was re-run on only those ﬁles that passed the Fluidigm
normalizer, but this had no eﬀect on the analysis outcome.
3.6. Intra- and inter-site diﬀerences-clustering algorithms
The manual gating analysis above enabled adjustments of the gates
as necessary to account for staining diﬀerences between sites, as well as
the increased background in certain channels for the site-stained sam-
ples. To explore to what extent this may aﬀect automated clustering,
principal component analysis (PCA) was ﬁrst performed on the 36
MATLAB-all normalized ﬁles (Suppl. Fig. S7). Due to parameter-naming
diﬀerences between certain sites, the FCS ﬁles ﬁrst had to be harmo-
nized using the cytofCore software package; Center_2_P1 was chosen as
the template ﬁle. Since we wanted to investigate possible diﬀerences
between sites, no attempt was made to batch-correct by site or any
other way. Combining each of the six samples from each of the six
centers and running a PCA for each sample highlighted the fact that no
signiﬁcant technical batch eﬀect exists between centers. Similarly,
calculating a PCA of all samples prepared by each center, highlights
that samples are comparable in a high-dimensional setting.
Fig. 1. Scheme of multicenter experiment. A.
Outline of reagent preparation for each site. A
master cocktail was mixed from 20 undiluted
antibodies. Six aliquots were made for distribu-
tion, then the remaining cocktail was used to
stain PBMCs to make Prestained sample aliquots
for each site. An unstained PBMC aliquot from
the same donor was also shipped for staining on-
site. B. Protocol for staining cells and sample
acquisition. One PBMC aliquot was thawed and
split, then stained on Day 1. On Day 2, each
sample was split into two parts. Part 1 was run on
the CyTOF that day, while part 2 was run on Day
3. Additionally, aliquots of Prestained sample
were thawed and run each day.
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Next, SPADE3 and Cytofkit (FlowSOM, ClusterX, and Rphenograph)
analyses were performed on the same harmonized MATLAB-normalized
ﬁles. The same 14 surface markers were used for clustering in both
SPADE3 and Cytofkit (see Section 2.6). The ﬁles were analyzed in three
ways: all 12 P ﬁles only, all 24 A and B ﬁles only (AB), and all 36 A, B,
and P ﬁles together (ABP). This would potentially allow us to separate
the diﬀerences from site-staining vs Prestained cells, from the diﬀer-
ences inherent to each site's machine operation.
Regardless of the clustering algorithm used, the results were similar
for the (Suppl. Fig. S9–S32). SPADE3's Earthmover's Distance calcula-
tions between each site's individual samples showed that the P-only
samples were more similar (EMD 0–2.4; Suppl. Fig. S12) than the AB-
only samples (EMD 0–5.7; Suppl. Fig. S13) or all ABP samples (EMD
0–4.3; Suppl. Fig. S14). Based on the frequencies of each cluster in the
ABP clustering calculations, each of the four algorithms demonstrated
that the P samples from each site were similar to each other but distinct
from the AB samples. Each algorithm also showed that the cluster fre-
quencies were more similar for certain pairs of centers than other pairs.
Centers 4 and 5 were paired, and Centers 1, 2, and 6 were a group;
Center 3 remained an outlier in comparison.
4. Discussion
With the comparatively young age of mass cytometry, much stan-
dardization is still needed to address CyTOF variability over time and
between instruments. Along with Tricot et al. (Tricot et al., 2015), this
study represents one of the ﬁrst tests of inter-site reproducibility of
staining and sample acquisition. First, it is possible to generate basic
Prestained control samples that are stable over time and tolerant of the
rigors of shipping, though this needs to be tested on a case-by-case basis
(Sumatoh et al., 2017). This approach allows the creation of an external
standard sample to complement day-of staining controls in order to
separate variation in experimental proﬁciency (cell thawing, stimula-
tion, staining) from variation in instrument performance.
We focused this study as a test of the proﬁciency of each site to
process samples and to acquire on their instruments. To remove site-
speciﬁc variations in antibody conjugation eﬃciency, we used only
commercially-available conjugated reagents. To avoid errors in pre-
paration of the 20-antibody cocktail, the primary site generated one
concentrated master mix and sent aliquots to each site. However, this
revealed that the concentrated antibody cocktail was itself not stable
and gave increased background for a handful of markers. Therefore, the
ability to make concentrated cocktail ahead of time is strongly
Fig. 2. Signal intensities of the metal isotopes present in
Fluidigm EQ Four-Element Beads vary by center. Each of
the normalization methods removes some of the inter-
center variation.
Fig. 3. Eﬀects of normalization on Frequency of Parent. The
Frequency of Parent Median and CV were calculated for
various manually gated cell populations for all samples, all
centers combined. The eﬀect of normalization was com-
pared to the Raw data.
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dependent on the exact antibodies used, and must be determined em-
pirically. Since not all antibodies were aﬀected, it may be possible to
create stable mixes of fewer antibodies and only add in the more pro-
blematic ones on-site. Alternatively, lyophilization or other dry-down
procedures may be utilized, but as yet, there are no mass cytometry
publications to demonstrate how broadly this may apply.
Between the six sites, there were some errors in marker/channel
naming that had to be resolved before batch analysis (manual or clus-
tering) could occur. The new Helios mass cytometer (Fluidigm) has the
ability to export a template ﬁle for experimental panels, which would
resolve this issue in future studies.
All six sites gave similar results for manual gating, demonstrating
overall technical proﬁciency. However, the concentration of beads
added to the sample makes a signiﬁcant diﬀerence in the ability to
normalize samples; indeed, one site had all six ﬁles fail to pass Fluidigm
normalization. Even without normalization, Frequency of Parent data
are comparable (CV < 30%) between Prestained and site-stained
samples. Similarly, MSI data are comparable (typical higher MSI
CV < 25%; low MSI CV < 50%) between diﬀerent days at the same
site, and between diﬀerent sites. Normalization made MSI data more
comparable between sites.
Automated analysis using several diﬀerent algorithms did detect
slight diﬀerences between cluster frequencies between sites. As ex-
pected, the main diﬀerence was between the P samples and the com-
bined AB samples, due in part to the increased background for certain
antibodies used as clustering parameters. The fact that certain pairs of
sites were more similar in cluster frequencies and Earthmover's distance
than to other sites does suggest batch-correction would further facilitate
removing the remaining inter-site diﬀerences.
Therefore, we conclude that inter-site studies are possible with mass
cytometry to a level comparable to ﬂuorescence ﬂow cytometry (Finak
et al., 2016; Kalina et al., 2015; Maecker et al., 2005).
Fig. 4. Eﬀects of normalization on median signal in-
tensity (MSI). The MSI median and CV were calculated
for various manually gated cell populations for all
samples, all centers combined. The eﬀect of normal-
ization was compared to the raw data. A. MSI ranging
from 800 to 100 Dual Counts. B. MSI ranging below 100
Dual Counts.
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Supplementary data to this article can be found online at https://
doi.org/10.1016/j.jim.2017.11.008.
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